Infusion pumps are medical instruments that infuse a patient's body with controlled fluids, such as nutrients and medications. Despite occasional arterial, subcutaneous, and epidural infusions, they are administered intravenously. With infusion pumps, fluids can be administered in ways that would be prohibitively unreliable or expensive if performed manually by nursing personnel. Infusion pumps are widely utilized in numerous clinical contexts, such as hospitals, home healthcare, and nursing homes. These facilities administer medication to patients needing emergency care, oncology treatment, and postoperative pain management.
In recent years, the increasing availability of alternative care services has positively affected the adoption rate of infusion devices. Infusion therapies and the demand for infusion devices have increased over time due to the growing demand for home healthcare and alternative care options. It is known that alternative sites for infusion therapies reduce medical costs by between 30 and 45% compared to hospitals, which has increased the demand for infusion devices.
Other services, such as flexible scheduling and high-quality medical care, have increased the demand for medical treatment facilities, such as alternative care sites (ACSs). Demand for alternative care sites and home-based healthcare services is driven by the increasing global burden of healthcare services, expanding geriatric population, and rising demand for chronic disease care. All of these factors should stimulate market expansion.
In particular patient care settings, intelligent infusion devices have recently been used for multiple therapies. These infusion pump variants provide various benefits in a brief amount of time and with comparatively lower costs in various clinical settings. Many hospitals have adapted innovative multipurpose and multitherapy infusion pumps to reduce staff workload and medication delivery errors.
Multipurpose infusion pumps are designed to ensure the accurate and timely delivery of multiple medications to two patients simultaneously. For example, Caesarea Medical Electronic (CME) manufactures multiple multipurpose infusion and hypodermic pump systems. The company's BodyGuard 323 Color Vision is a sophisticated multitherapy infusion pump primarily used in hospitals. Such factors create opportunities for market growth.
North America is the most significant global infusion pump market shareholder and is anticipated to exhibit a CAGR of 7.82% during the forecast period. North America is a developed region regarding healthcare services and technology implementation. The North American infusion pump market growth has been fueled by factors such as the escalating rate of technological innovation and the adoption of medical devices for drug delivery. In addition, the surging prevalence of chronic illnesses like diabetes and cancer drives up demand for infusion devices in North America. As per the IDF Diabetes Atlas, the number of diabetic individuals was approximately 48 million in 2019 and will increase by 33% to reach 63 million by 2045. Nearly 80–90% of hospitals in the United States use innovative infusion devices. In the United States, there are 0.5 million insulin infusion pump users, while 10% of the diabetic population in Canada utilizes insulin infusion pumps. Such factors drive regional market growth.